Alkaptonuria- a rare metabolic disorder
DOI:
https://doi.org/10.66344/jpad.15.4.2005.671Keywords:
Alkaptonuria, homogentisic acid, ochronosis, arthritisAbstract
A 26-year-old male presented with bluish discoloration of both pinnae and history of arthritis for the last few months. Examination showed bluish pigmentation of both pinnae, rest of the examination was unremarkable. Urine examination for the diagnosis of alkaptonuria was positive; however no radiological changes were seen at this stage of the disease. No other systemic abnormality or complication detected.References
Phornphutkul C, Introne WJ, Perry MB et al. Natural history of alkaptonuria. N Engl J Med 2002; 347: 2111-21.
La Du BN. Alkaptonuria. In: Scriver CR, Beaudet AL, Sly WS et al., editors. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: Mcgraw-Hill; 2001. p. 2109-23.
Smith JW. Ochronosis of the sclera and cornea complicating alkaptonuria: review of the literature and report of four cases. JAMA 1942; 120: 1282-7.
Touart DM, Sau P. Cutaneous deposition diseases: part II. J Am Acad Dermatol 1998; 39: 527-44.
Lustberg TJ, Schulman JD, Seegmiller JE. The preparation and identification of various adducts of oxidized homogentisic acid and the development of a new sensitive calorimetric assay for homogentisic acid. Clin Chim Acta 1971; 35: 325-33.
Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 3rd edn. Philadelphia: WB Saunders; 1998.
Sealock RR, Gladstone M, Steele JM. Administration of ascorbic acid to an alkaptonuric patient. Proc Soc Exp Biol Med 1940; 44: 580-3.
Mitchell GA, Grompe M, Lambert M, Tanguay RM. Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS et al., eds. The Metabolic and Molecular bases of Inherited Disease, 8th edn. New York: McGraw-Hill; 2001. p.1777-1805.
Eisen D, Hakin MD. Minocyclin-induced pigmentation: incidence, prevention and management. Drug Saf 1998; 18: 431-40.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
